These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3655365)

  • 1. Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation.
    Lévi-Strauss M; Mallat M
    J Immunol; 1987 Oct; 139(7):2361-6. PubMed ID: 3655365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 6 stimulates synthesis of complement proteins factor B and C3 in human skin fibroblasts.
    Katz Y; Revel M; Strunk RC
    Eur J Immunol; 1989 Jun; 19(6):983-8. PubMed ID: 2473911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2.
    Andoh A; Fujiyama Y; Bamba T; Hosoda S
    J Immunol; 1993 Oct; 151(8):4239-47. PubMed ID: 8409399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the synthesis of the third component of complement and factor B in cord blood monocytes by lipopolysaccharide.
    Sutton MB; Strunk RC; Cole FS
    J Immunol; 1986 Feb; 136(4):1366-72. PubMed ID: 3003195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of factors D, B and P of the alternative pathway of complement activation, as well as of C3, by guinea-pig peritoneal macrophages in vitro.
    Bentley C; Fries W; Brade V
    Immunology; 1978 Dec; 35(6):971-80. PubMed ID: 104925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of complement components (C3, C2, B and C1-inhibitor) and lysozyme by human monocytes and macrophages.
    Lappin D; Hamilton AD; Morrison L; Aref M; Whaley K
    J Clin Lab Immunol; 1986 Jul; 20(3):101-5. PubMed ID: 3638367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation during CAPD.
    Young GA; Kendall S; Brownjohn AM
    Nephrol Dial Transplant; 1993; 8(12):1372-5. PubMed ID: 8159307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.
    Strunk RC; Eidlen DM; Mason RJ
    J Clin Invest; 1988 May; 81(5):1419-26. PubMed ID: 2966814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of chrysotile asbestos fibres with the complement system.
    Saint-Remy JM; Cole P
    Immunology; 1980 Oct; 41(2):431-7. PubMed ID: 6904360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activation of the alternative complement pathway in pleural fluid of patients with pneumonia].
    Aguado MT; Celada A
    Allergol Immunopathol (Madr); 1982; 10(3):215-20. PubMed ID: 6924537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human alternative complement pathway: biology and immunopathology of activation and regulation.
    Kazatchkine MD; Nydegger UE
    Prog Allergy; 1982; 30():193-234. PubMed ID: 7041132
    [No Abstract]   [Full Text] [Related]  

  • 13. Activated factor B (Bb) of the alternative pathway of complement activation cleaves and activates plasminogen.
    Sundsmo JS; Wood LM
    J Immunol; 1981 Sep; 127(3):877-80. PubMed ID: 6911148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional active complement components secreted by guinea pig peritoneal macrophages.
    Brade V; Kreuzpaintner G
    Immunobiology; 1982 Apr; 161(3-4):315-21. PubMed ID: 7047377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A mechanism of human complement activation by immunostimulators from the bacterial cell wall].
    Kozlov LV; Zinchenko AA; Soliakov LS; Sizoĭ MN; Ishchenko AM
    Bioorg Khim; 1983 Aug; 9(8):1047-55. PubMed ID: 6680304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [C3, C4, factor B components in septic states].
    Laurent P; Goudot B; Grozel JM
    Nouv Presse Med; 1978 Jul 1-8; 7(27):2406. PubMed ID: 673827
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement activation in Staphylococcus aureus bacteraemia.
    Hallett AF; Cooper R
    Clin Exp Immunol; 1980 May; 40(2):306-11. PubMed ID: 6904257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Components C3, C4 and B factor of complement system in the course of septic states of different levels of seriousness (author's transl)].
    Goudot-Patay B; Laurent P; Grozel JM
    Anesth Analg (Paris); 1979; 36(7-8):301-6. PubMed ID: 525835
    [No Abstract]   [Full Text] [Related]  

  • 19. Granulocyte-macrophage colony-stimulating factor, but not macrophage colony-stimulating factor, suppresses basal and lipopolysaccharide-stimulated complement factor production in human monocytes.
    Høgåsen AK; Hestdal K; Abrahamsen TG
    J Immunol; 1993 Sep; 151(6):3215-24. PubMed ID: 7690797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the alternative complement pathway by normal and transformed cells in homologous and heterologous sera.
    McConnell I; Gorman NT; Raniwalla J; Powell P
    Eur J Immunol; 1981 Feb; 11(2):126-32. PubMed ID: 6260511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.